“A universal ingredient”: Biotech start-up Enifer begins large-scale mycoprotein factory construction

Finnish biotech startup Enifer, with €12 million (US$13.1 million) in funding from the EU NextGenerationEU instrument plans to build a factory for its Pekilo mycoprotein production. We sit down with the company’s COO and discuss its unique fungal strain, efficient fermentation process and application versatility.

MESSAGE FROM FRIESLANDCAMPINA INGREDIENTS

Shaping the Future of Nutrition with FrieslandCampina Ingredients

The secret to success in adult nutrition lies in aligning with what people really want. 25% of consumers say there’s a lack of available products that fit their specific requirements. Download this report from FrieslandCampina Ingredients to see how you can help people get the most out of life, always.

Today’s Top Stories

► Maintaining healthy cell energy: Bioenergy counters the effect of fructose with ribose
► Plant molecule identified that boosts resistance to bacterial attacks, study flags
► Potato cultivars look to tackle post-harvest losses and ensure year-round supply

► Meati Foods review finds nutrient-dense mycelium can “address world hunger”
► Pet microbiome: Hill’s Pet Nutrition debuts prescription diets for food sensitivities

Ingood by Olga spotlights plant-based pea protein opportunities in sports nutrition

The nutritional advantages of pea protein along with its environmentally-friendly profile is increasing the ingredient’s popularity among active consumers. We sit down with Claire Boniface, Ingood by Olga’s marketing and communication manager, about the benefits of Peakara pea protein, a plant-based alternative to animal proteins for post-workout recovery.

CRN issues warning against tianeptine presence in misbranded dietary supplements

The Council for Responsible Nutrition (CRN) warns against dietary supplements containing the antidepressant tianeptine due to severe health risks, including potential abuse and adverse neurological, cardiovascular and gastrointestinal effects. We look at the organization’s warnings against the use of these unapproved and often misleading products.